Avonex (Biogen Idec, MA, USA), a drug indicated for relapsing multiple sclerosis (MS), has reached Japan. It was first launched in 1994 in the USA and later in Europe and it is now serving approximately 130,000 patients in more than 90 countries worldwide. MS is an autoimmune disorder ...
Acetaminophen, which is the analgesic of choice for patients using warfarin, has case reports17,242 as well as a case-control study243 suggesting moderate potentiation (perhaps based on mild factor VII depletion17,243), although findings from an RCT in healthy volunteers were negative.244 The ...
Amphetamineis the growing drug of choice for adults in the United States, including pregnant women. (Meth)amphetamine use during pregnancy has typically been associated with social disadvantage, multiple drug use, domestic violence, and significant health and mental health problems. The effects of usin...
Cell therapy for multiple sclerosis Hematopoietic stem cell transplantation for multiple sclerosis Embryonic stem cells and neural precursor cells for MS Gene therapy for multiple sclerosis Drug delivery in epilepsy Routes of administration of antiepileptic drugs ...
Your privacy, your choice We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including ...
New drugs for multiple sclerosis. Leeds: NHS Executive, 1995 Bonn D. UK interferon-β-1b trial for treatment of multiple sclerosis shelved. Lancet 1996; 348: 538 CrossRef Cardy P. Equity in prescribing. A Fabian Society Meeting: 1997 Feb 28; London UK court to decide on MS funding....
Biologics or biologic drugs are products made from living organisms or contain components of living organisms. Biologics treat many conditions, for example, cancers, rheumatoid arthritis, inflammatory bowel disease, MS, psoriasis, lupus, chronic migraine
Your privacy, your choice We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including ...
Baclofen is a selective GABA-B receptor agonist administered in the treatment of paraplegia, multiple sclerosis and serious central or spinal neurological diseases. A series of trials have demonstrated the effectiveness of baclofen in alcohol-dependent patients [[64], [65], [66]], but these result...
Introduction In September 2022, the US Food and Drug Administration (FDA) Peripheral and Central Nervous System Drugs Advisory Committee met for an unusual second session to discuss the amyotrophic lateral sclerosis drug now approved and marketed as Relyvrio (sodium phenylbutyrate and taur...